Financials
- Market Capitalization 412.74 M
- Employee 35
- Founded 1996
- CEO N/A
- Website www.fennecpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000DTH814
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3050 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.23 USD | +1.44% | +4.44% | +7.63% | +42.42% | 419.39 M USD | ||
| 3052 | GALT Galectin Therapeutics Inc. - Common Stock | 4.14 USD | -0.24% | +14.36% | +20.70% | -1.43% | 417.52 M USD | ||
| 3069 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.99 USD | -0.40% | -2.54% | +13.67% | +3.74% | 409.41 M USD | ||
| 3074 | IPSC Century Therapeutics, Inc. - Common Stock | 2.23 USD | +4.21% | +8.78% | +9.31% | +337.25% | 403.80 M USD |
Frequently asked questions about Fennec Pharmaceuticals Inc. Common Stock
What is the Fennec Pharmaceuticals Inc. Common Stock stock price today?
The current price of Fennec Pharmaceuticals Inc. Common Stock (FENC) is 11.77. Over the past 24 hours, the stock has changed by -3.29%. Follow the FENC chart for real-time price dynamics.
What is the stock ticker of Fennec Pharmaceuticals Inc. Common Stock?
Fennec Pharmaceuticals Inc. Common Stock trades under the ticker FENC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fennec Pharmaceuticals Inc. Common Stock stock going up?
FENC has changed by +2.62% over the last week, +17.00% over the last month, and +31.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Fennec Pharmaceuticals Inc. Common Stock?
Fennec Pharmaceuticals Inc. Common Stock currently has a market capitalization of 412.74 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Fennec Pharmaceuticals Inc. Common Stock earnings last quarter?
Last quarter, Fennec Pharmaceuticals Inc. Common Stock reported earnings of 0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Fennec Pharmaceuticals Inc. Common Stock revenue for the last quarter?
Fennec Pharmaceuticals Inc. Common Stock reported quarterly revenue of 17.87 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Fennec Pharmaceuticals Inc. Common Stock net income for the last quarter?
Fennec Pharmaceuticals Inc. Common Stock reported net income of 1.97 M for the last quarter. The previous quarter showed 201 K, which means net income changed by +881.59%.
How many employees does Fennec Pharmaceuticals Inc. Common Stock have?
As of the latest available data, Fennec Pharmaceuticals Inc. Common Stock has 35 employees. Workforce size can provide additional context about the company's scale and operations.
What is Fennec Pharmaceuticals Inc. Common Stock EBITDA?
Fennec Pharmaceuticals Inc. Common Stock EBITDA is 1.76 M, and its EBITDA margin is 9.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Fennec Pharmaceuticals Inc. Common Stock stock?
You can buy Fennec Pharmaceuticals Inc. Common Stock (FENC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fennec Pharmaceuticals Inc. Common Stock stock?
Investing in Fennec Pharmaceuticals Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FENC chart and related analysis on metatrader.com as part of your research.